PL376755A1 - Zastosowanie R-10-hydroksy-10,11-dihydrokarbamazepiny w bólach neuropatycznych - Google Patents
Zastosowanie R-10-hydroksy-10,11-dihydrokarbamazepiny w bólach neuropatycznychInfo
- Publication number
- PL376755A1 PL376755A1 PL376755A PL37675504A PL376755A1 PL 376755 A1 PL376755 A1 PL 376755A1 PL 376755 A PL376755 A PL 376755A PL 37675504 A PL37675504 A PL 37675504A PL 376755 A1 PL376755 A1 PL 376755A1
- Authority
- PL
- Poland
- Prior art keywords
- carbamazepine
- dihydro
- hydroxy
- neuropathic pain
- neuropathic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0303615.9A GB0303615D0 (en) | 2003-02-17 | 2003-02-17 | Use of organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PL376755A1 true PL376755A1 (pl) | 2006-01-09 |
Family
ID=9953162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL376755A PL376755A1 (pl) | 2003-02-17 | 2004-02-16 | Zastosowanie R-10-hydroksy-10,11-dihydrokarbamazepiny w bólach neuropatycznych |
Country Status (11)
Country | Link |
---|---|
US (3) | US20060166967A1 (pl) |
EP (1) | EP1596865A1 (pl) |
JP (1) | JP2006517940A (pl) |
CN (1) | CN1750826A (pl) |
AU (1) | AU2004212327A1 (pl) |
BR (1) | BRPI0407529A (pl) |
CA (1) | CA2516265A1 (pl) |
GB (1) | GB0303615D0 (pl) |
MX (1) | MXPA05008711A (pl) |
PL (1) | PL376755A1 (pl) |
WO (1) | WO2004071513A1 (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
EP2380574A1 (en) * | 2005-05-06 | 2011-10-26 | Bial-Portela & CA, S.A. | Eslicarbazepine acetate and methods of use |
GB0517740D0 (en) * | 2005-08-31 | 2005-10-12 | Novartis Ag | Organic compounds |
GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
WO2011017319A1 (en) * | 2009-08-03 | 2011-02-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of treating disorders associated with protein polymerization |
US8809617B2 (en) | 2009-11-05 | 2014-08-19 | The University of Pittsburgh—Of the Commonwealth System of Higher Education | Automated high-content live animal drug screening using C. elegans |
US9072772B2 (en) | 2009-11-05 | 2015-07-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods of treating disorders associated with protein aggregation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH505101A (de) * | 1969-03-31 | 1971-03-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Azepinderivaten |
EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
US5534495A (en) * | 1993-05-25 | 1996-07-09 | Advanced Peptides And Biotechnology Sciences | Treatment of non-HIV neuropathic pain syndromes |
US5688830A (en) * | 1996-01-25 | 1997-11-18 | Syntex (U.S.A.) Inc. | Treatment of neuropathic pain |
GB0112812D0 (en) * | 2001-05-25 | 2001-07-18 | Portela & Ca Sa | Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom |
KR20050044396A (ko) * | 2001-11-12 | 2005-05-12 | 노파르티스 아게 | 정동 및 주의력 장애 및 신경병성 통증 치료용 의약제조에 사용하기 위한 모노히드록시카르바마제핀 |
EP1528927A1 (en) * | 2002-08-06 | 2005-05-11 | Novartis AG | Use of carboxamides for the treatment of tinnitus |
GB0223224D0 (en) * | 2002-10-07 | 2002-11-13 | Novartis Ag | Organic compounds |
-
2003
- 2003-02-17 GB GBGB0303615.9A patent/GB0303615D0/en not_active Ceased
-
2004
- 2004-02-16 JP JP2006501857A patent/JP2006517940A/ja active Pending
- 2004-02-16 CA CA002516265A patent/CA2516265A1/en not_active Abandoned
- 2004-02-16 AU AU2004212327A patent/AU2004212327A1/en not_active Abandoned
- 2004-02-16 PL PL376755A patent/PL376755A1/pl not_active Application Discontinuation
- 2004-02-16 MX MXPA05008711A patent/MXPA05008711A/es not_active Application Discontinuation
- 2004-02-16 BR BRPI0407529-3A patent/BRPI0407529A/pt not_active IP Right Cessation
- 2004-02-16 WO PCT/EP2004/001451 patent/WO2004071513A1/en not_active Application Discontinuation
- 2004-02-16 EP EP04711348A patent/EP1596865A1/en not_active Withdrawn
- 2004-02-16 CN CNA2004800044023A patent/CN1750826A/zh active Pending
-
2005
- 2005-02-16 US US10/545,410 patent/US20060166967A1/en not_active Abandoned
-
2008
- 2008-10-30 US US12/261,655 patent/US20090054404A1/en not_active Abandoned
-
2009
- 2009-12-08 US US12/633,231 patent/US20100120746A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004071513A1 (en) | 2004-08-26 |
CN1750826A (zh) | 2006-03-22 |
BRPI0407529A (pt) | 2006-02-14 |
GB0303615D0 (en) | 2003-03-19 |
US20100120746A1 (en) | 2010-05-13 |
JP2006517940A (ja) | 2006-08-03 |
US20090054404A1 (en) | 2009-02-26 |
US20060166967A1 (en) | 2006-07-27 |
MXPA05008711A (es) | 2005-10-05 |
EP1596865A1 (en) | 2005-11-23 |
AU2004212327A1 (en) | 2004-08-26 |
CA2516265A1 (en) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL227988A0 (en) | Use of calcitonin in osteoarthritis | |
EP1689485A4 (en) | CARDIOELECTROMAGNETIC TREATMENT | |
GB0307918D0 (en) | Therapeutic use | |
EP1607081A4 (en) | COSMETIC PREPARATION | |
GB0326486D0 (en) | Combination treatment | |
GB0312407D0 (en) | Treatment | |
GB0315259D0 (en) | Use | |
GB0306604D0 (en) | Second medical use | |
PL376755A1 (pl) | Zastosowanie R-10-hydroksy-10,11-dihydrokarbamazepiny w bólach neuropatycznych | |
GB0302741D0 (en) | Use | |
GB0318546D0 (en) | Quinoxalinones and their use | |
GB2398740B (en) | Skin composition | |
GB0313913D0 (en) | New use | |
GB0305089D0 (en) | Composition, use and process | |
EP1660088A4 (en) | PYRIDOMORPHINANES, PYRIDAZINOMORPHINANES AND USE THEREOF | |
GB0316757D0 (en) | Use | |
TW571940U (en) | Officejet | |
GB0327619D0 (en) | New use | |
GB0327195D0 (en) | Novel use | |
EP1625830A4 (en) | MEDICAL MANIPULATOR | |
AU3274P (en) | Sunspot Heucherella xtiarelloides | |
GB0325977D0 (en) | Use | |
GB0325976D0 (en) | Use | |
GB0323861D0 (en) | Use | |
GB0310755D0 (en) | Use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |